-transparent.png){kind=logo}
A new selective medium has been developed for cells containing the enzyme deoxycytidine deaminase. This medium contains hypoxanthine, aminopterin, and 5-methyldeoxycytidine (HAM medium). To survive in the presence of the aminopterin, the cells must utilize deoxycytidine deaminase to convert the 5-methyldeoxycytidine to thymidine. The cells must also have thymidine kinase and hypoxanthine phosphoribosyltransferase. A mouse cell line deficient in deoxycytidine deaminase has been isolated from a deoxycytidine kinase-deficient line, using 5-bromodeoxycytidine as the selective agent. A hybrid line between this double mutant and a human diploid fibroblast was isolated in HAM medium. The hybrid line contains the chromosomes expected of a human-mouse hybrid. The deoxycytidine deaminase isozyme patterns on cellogel show that the human-mouse hybrid cell line produces an enzyme with an electrophoretic mobility intermediate between that of the human and that of the mouse.
T S Chan, and
C Long, and
H Green
January 1976,
Birth defects original article series,
T S Chan, and
C Long, and
H Green
January 1976,
Cytogenetics and cell genetics,
T S Chan, and
C Long, and
H Green
January 1993,
European journal of cancer (Oxford, England : 1990),
T S Chan, and
C Long, and
H Green
January 1978,
Biochimica et biophysica acta,
T S Chan, and
C Long, and
H Green
January 2002,
Journal of biomedical science,
T S Chan, and
C Long, and
H Green
July 1975,
Experimental cell research,
T S Chan, and
C Long, and
H Green
January 1970,
Enzymologia biologica et clinica,
T S Chan, and
C Long, and
H Green
October 1977,
Journal of the National Cancer Institute,
T S Chan, and
C Long, and
H Green
January 1971,
Proceedings of the National Academy of Sciences of the United States of America,
T S Chan, and
C Long, and
H Green
November 1998,
Biochemical pharmacology,
